Sarepta Therapeutics has clarified that the deaths of two patients involved in its Elevidys gene therapy trials were not related to the treatment i...
Sarepta Therapeutics has announced that the deaths of two patients who were treated with its gene therapy Elevidys for Duchenne muscular dystrophy ...
A class action lawsuit has been filed against Sarepta Therapeutics by Levi & Korsinsky, alleging that shareholders purchased SRPT stock at inflated...
Sarepta Therapeutics has clarified that the deaths of two patients who were taking its gene therapy Elevidys, reported on the FDA database, were no...
Rosen Law Firm is reminding investors of Sarepta Therapeutics, Inc. about the August 25, 2025, deadline to serve as lead plaintiff in a securities ...
The Rosen Law Firm has issued a reminder to investors of Sarepta Therapeutics, Inc. regarding an upcoming deadline for a securities class action la...
Recent developments in biotechnology have showcased significant advancements in medical research. A study has demonstrated that hypoxia, or low oxy...
Sarepta Therapeutics, Inc., a biopharmaceutical company, is facing a securities fraud lawsuit filed by Bleichmar Fonti & Auld LLP. The lawsuit alle...
Vinay Prasad has been reinstated at the Food and Drug Administration (FDA) to lead the Center for Biologics Evaluation and Research. This decision ...
Sarepta Therapeutics, a biopharmaceutical company, is facing a securities fraud lawsuit filed by Bleichmar Fonti & Auld LLP. The lawsuit alleges th...